Correspondence
To the Editor: Large granular lymphocytic leukemia (LGLL) is a rare chronic clonal lymphoproliferative disease characterized by a persistent increase in large granular lymphocytes, which are large lymphocytes with a low nucleus to cytoplasm ratio and an abundant cytoplasm with azurophilic granules. [1] Here we report two cases diagnosed as refractory LGLL treated with porcine antihuman thymocyte immunoglobulin (ATG) in West China Hospital.
A 44-year-old woman was admitted to the outpatient department with complaint of recurrent fatigue. The initial laboratory tests showed: Hemoglobin (Hb), 6.8 g/dl, reticulocytes (RET), 7. Figure 1a ]. Then, FCM of marrow suggested that just a few clonal T-cell might be presented. 7 months later, FCM of her peripheral blood showed nucleated cells with 38% lymphocytes, 68% of which were clonal cytotoxic T-cell. She was identified to relapse.
A 46-year-old woman was admitted to our department due to dizziness and fatigue. Her initial laboratory tests showed: Hb 5.5 g/dl, RET 28 × 10 9 /L; bone marrow smear showed mature lymphocytes of 21%, granulocytic cells 71%; erythroid cells 7% and M/E ratio 10 In 1977, LGLL was first described by McKenna; in 1985, the term LGLL was first used to describe this disorder involving clonal invasion of the blood, marrow and spleen; in 1999, the World Health Organization classification included T-and NK-cell LGLL in the mature peripheral T-cell neoplasm subgroup. [2] The disease mainly affects middle-aged people, with a median age of 60 years, without gender predilection. [3] It is asymptomatic or symptomatic with neutropenia, anemia, thrombocytopenia, recurrent infections and autoimmune conditions. The FCM is often characterized by expression of CD3 + , CD8 + , and TCR-γ gene rearrangements. suggested that purine analogs, such as Fludarabine or Campath, could be used or that investigational drugs should be considered. [4] Although ATG can bind to T-cell and relieve inhibition of red linage, few refractory patients received the treatment. We searched OVID databases and found that patients with refractory LGLL were treated with horse ATG in 1980s; no patients have been treated by porcine ATG before. Our two refractory patients received porcine ATG therapy and achieved remission. One of them even achieved molecular remission. However, one patient relapsed afterwards, so long-term follow-up is also necessary to monitor the recurrence.
